
Latest Health News
📅February 8, 2026 at 1:00 PM
Global health faces infectious disease outbreaks like Nipah and measles, US WHO withdrawal impacts funding and surveillance, plus MS drug advances and new monitoring tech.
6
Genentech's Fenebrutinib Reduces MS Disability
Fenebrutinib met non-inferiority to Ocrevus in reducing disability progression in primary progressive MS, with 12% risk reduction by week 24, per Phase III results on February 7, 2026. Regulatory submission planned mid-2026; potential first oral brain-penetrant BTK inhibitor.